• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Barriers to Surrogate Application of Patient Values in Medical Decisions in Acute Stroke: Qualitative Study in a Biethnic Community
ConclusionsStroke surrogate decision-makers may benefit from (1) continued efforts to make advance care planning more common and more relevant, (2) assistance in how to apply their knowledge of patient values to actual treatment decisions, and (3) psychosocial support to reduce emotional burden. Barriers to surrogate application of patient values were generally similar in MA and NHW participants, though the possibility of greater guilt or burden among MA surrogates warrants further investigation and confirmation.
Source: Neurocritical Care - May 2, 2023 Category: Neurology Source Type: research

Delivering acute stroke care in a middle-income country. The Mexican model: “ResISSSTE Cerebro”
ConclusionWith the implementation of a modified hub-and-spoke model, this study shows that delivery of AS care in low- and middle-income countries is feasible and achieves good clinical outcomes.
Source: Frontiers in Neurology - February 22, 2023 Category: Neurology Source Type: research

The association between HDL ‐C and stroke in the middle‐aged and elderly: A cross‐sectional study
ConclusionWe found a nonlinear relationship between HDL-C and total stroke. Our study reveals a range of inverse associations between HDL-C and stroke (HDL-C<1.55  mmol/L), especially among men and Whites. This finding suggested that maintaining an appropriate HDL-C range may be beneficial in reducing the incidence of stroke.
Source: Brain and Behavior - February 7, 2023 Category: Neurology Authors: Yang Hu, Min Song, Dongmei Wu, Yuqing Zhang, Gongbo Li, Haiyan Luo Tags: ORIGINAL ARTICLE Source Type: research

Cognitive recovery trajectories 3 months following stroke in Mexican American and non-Hispanic white adults
Cognitive impairment is common after stroke1, is associated with increased mortality, cost of care and disability2, and negatively impacts post-stroke quality of life3. Mexican Americans (MAs) demonstrate worse cognitive, neurologic, and functional outcomes 90 days following stroke compared to non-Hispanic white (NHWs)4. Although it is established that MAs demonstrate poorer 90-day cognitive outcomes following stroke than NHW, it is unclear whether MA disparities in cognitive outcomes are present immediately after stroke or whether the 90-day cognitive outcome disparities reflect a less favorable recovery trajectory in MAs.
Source: Journal of Stroke and Cerebrovascular Diseases - November 29, 2022 Category: Neurology Authors: Emily M. Brice ño, Liming Dong, Deborah A. Levine, Madeline Kwicklis, Lynda D. Lisabeth, Lewis B. Morgenstern Source Type: research

Methods and early recruitment of the Brain Attack Surveillance in Corpus Christi —Post-acute Care (BASIC-PAC) Project
Mexican Americans (MAs) are the most numerous sub-group of Latinx, the largest minority population in the United States. This important sub-group is aging and growing rapidly. Stroke incidence is similar in MAs compared with non-Hispanic whites (NHWs),1 and MA stroke survivors have worse neurologic, functional, cognitive and quality of life outcomes at 90-days post-stroke compared with NHWs for reasons that are not completely understood.2 Worse stroke outcomes in MAs are not fully explained by socio-demographics, including education and insurance, stroke treatment, stroke severity or subtype, or pre-stroke factors.
Source: Journal of Stroke and Cerebrovascular Diseases - November 3, 2022 Category: Neurology Authors: Lewis B. Morgenstern, Elizabeth M. Almendarez, Roshanak Mehdipanah, Madeline Kwicklis, Erin Case, Melinda A. Smith, Lynda D. Lisabeth Source Type: research

Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria
CONCLUSION: GBS is a frequent autoimmune neuropathy that has been associated with preceding infections and with vaccination campaigns. For SARS-CoV-2 vaccination campaign in Mexico, validation of Brighton Criteria is necessary. Although Mexico's GBS epidemiology has been changing throughout recent years, this study provides similar data compared to other countries.PMID:35383873 | DOI:10.33588/rn.7408.2021437
Source: Revista de Neurologia - April 6, 2022 Category: Neurology Authors: J C L ópez-Hernández J A Galnares-Olalde A Guti érrez S A Estrada M Garc ía-Grimshaw E S Vargas-Ca ñas Source Type: research

Pages: 1  2  3